It is therefore likely that the combination of both cell-autonomous and non-cell autonomous effects of ALS-linked FUS variants in different cell-types contributes to the severity of ALS/FTD pathology that is observed in humans. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.